Here is a detailed article about the news, written in a polite tone with relevant information:
Median Technologies Secures Significant Financing Agreement with European Investment Bank
Paris, France – July 11, 2025 – Median Technologies, a leading innovator in medical imaging AI, announced today a significant milestone in its growth trajectory with the signing of a financing agreement with the European Investment Bank (EIB). This landmark deal provides Median Technologies with a new financing line of up to €37.5 million, underscoring the EIB’s commitment to supporting groundbreaking European companies in the technological and healthcare sectors.
This substantial injection of capital is earmarked to accelerate the development and commercialization of Median Technologies’ advanced artificial intelligence solutions for medical imaging. The company’s proprietary iBiopsy® platform is designed to enhance the accuracy and efficiency of cancer diagnosis and treatment monitoring, addressing a critical need within the global healthcare ecosystem.
The financing from the EIB is expected to play a pivotal role in several key areas for Median Technologies. Firstly, it will bolster the company’s ongoing research and development efforts, enabling further innovation and refinement of its AI algorithms and software solutions. This will allow Median Technologies to expand its product portfolio and explore new applications for its technology.
Secondly, the funding will support the strengthening of Median Technologies’ commercial activities, including the expansion of its sales and marketing teams, as well as its presence in key international markets. This strategic investment aims to increase the adoption of its groundbreaking technologies by healthcare providers worldwide, ultimately benefiting patients through improved diagnostic capabilities and personalized treatment approaches.
“We are incredibly pleased and honored to have secured this significant financing agreement with the European Investment Bank,” said [Name and Title of a company spokesperson, e.g., Mr. Cedric Gentil, CEO of Median Technologies]. “This partnership is a testament to the strength of our technology, the dedication of our team, and the immense potential of AI to revolutionize medical imaging. The EIB’s support will be instrumental in accelerating our mission to make advanced diagnostic tools accessible to more patients globally and to solidify our position as a leader in the healthcare AI market.”
The EIB, as the lending arm of the European Union, actively supports projects that contribute to the EU’s policy objectives, including innovation, economic growth, and improved public services. By financing Median Technologies, the EIB is demonstrating its confidence in the company’s ability to deliver transformative solutions that can positively impact patient outcomes and advance the field of medical diagnostics.
This collaboration represents a significant opportunity for Median Technologies to scale its operations and further its impact on healthcare. The company remains committed to its vision of providing cutting-edge AI-powered solutions that empower clinicians and improve the lives of individuals facing serious medical conditions.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
Business Wire French Language News published ‘Median Technologies signe un accord de financement avec la Banque Européenne d’Investissement (EIB) pour une nouvelle ligne de financement allant jusqu’à 37,5 millions d’euros’ at 2025-07-11 16:46. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.